|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Assessing liver fi- brosis with serum marker models显示文摘 | Rossi E Adams LA Bulsara M | 2007 | Clin Biochem Rev2007，28，： | 1 |
| 2 | Therapeutic Monitoring of Vancomycin in Adult Patients:A Consensus Review of the American Society of Health-SystemPharmacists, the Infectious Diseases Society of America, and thesociety of Infectious Dis- eases Pharmacists显示文摘 | Martin JH Norris R Barras M | 2010 | Clin Biochem Rev2010，31，2： | 1 |
| 3 | Estimating glomerular filtration rate in diabetes using serum cystatin C 显示文摘 | Macisaac R J Premaratne E Jerums G | 2011 | Clin Biochem Rev2011，32，2： | 1 |
| 4 | Cystatin C paradigm of evidence based laboratory medicine显示文摘 | Chew JS Saleem M Florwski CM | 2008 | Clin Biochem Rev2008，29，2： | 1 |
| 5 | Cystatin-C- a para digm of evidence based laboratory medicine 显示文摘 | Chew JS Saleem M Florkowski CM | 2008 | Clin Biochem Rev2008，29，2： | 1 |
| 6 | Therapeutic monitoring of vancomycin in adult patients:a consensus review of the American Society of Health-System Pharmacists,the Infectious Diseases Society of America,and the Society Of Infectious Diseases Pharmacists显示文摘 | Martin JH Norris R Barras M | 2010 | Clin Biochem Rev2010，31，1： | 1 |
| 7 | International Expert Committee report on the role of the Alc assay in the diagnosis of diabetes:Diabetes Care 2009,32(7):1327-1334显示文摘 | Gillett MJ | 2009 | Clin Biochem Rev2009，30，4： | 1 |
| 8 | HbAlc stan- dardisation : history, science and politics 显示文摘 | John WG Mosca A Weykamp C | 2007 | Clin Biochem Rev2007，28，4： | 1 |
| 9 | Autocrine and paracrine actions of vitamin D显示文摘 | Morris HA Anderson PH | 2010 | Clin Biochem Rev2010，31，： | 1 |
| 10 | Uncertainly of measurement in quantitative medical testing显示文摘 | White GH Farrance I | 2004 | Clin Biochem Rev2004，252，： | 1 |
| 11 | Estimating glo merular filtration rate in diabetes using serum cystatin C 显示文摘 | Maeisaae RJ Premaratne E Jerums G | 2011 | Clin Biochem Rev2011，32，2： | 1 |
| 12 | Estimating glomerular fil- tration rate in diabetes using serum cystatin C显示文摘 | Maeisaae RJ Premaratne E Jerums G | 2011 | Clin Biochem Rev2011，32，2： | 1 |
| 13 | The joint committee for traceability in laboratory medicine (JCTLM):A global approach to promote the standardisation of clinical laboratory test results显示文摘 | David A Richard R M | 2007 | Clin Biochem Rev2007，28，3： | 1 |
| 14 | Assessing liver fibrosis with serum marker models 显示文摘 | ROSSI E ADAMS L A BUISARA M etal | 2007 | Clin Biochem Rev2007，28，1： | 1 |
| 15 | How, why, where and when--a tortuous pathway from kit manufacturers, via inter-labo-ratory lyophilized and whole blood comparisons to designated national comparison schemes 显示文摘 | Goodall I HbAlc standardisation destination-global IFCC standardisation | 2005 | Clin biochem Rev2005，26，1： | 1 |
| 16 | Laboratory turnaround time显示文摘 | Hawkins RC | 2007 | Clin Biochem Rev2007，28，4： | 1 |
| 17 | Current concepts and future directions in differentia- ted thyroid cancer显示文摘 | McLeod DS | 2010 | Clin Biochem Rev2010，31，1： | 1 |
| 18 | Cystatin C a paradigm of evidence based laboratory medicine显示文摘 | Chew JS Saleem M Florkowski CM | 2008 | Clin Biochem Rev2008，29，2： | 1 |
| 19 | Faecal occult blood teste:choice,usege and clinical applications显示文摘 | Youg G P | 1992 | Clin Biochem Rev1992，13，2： | 1 |
| 20 | George Cystatin C paradigm of evidence based laboratory medicine 显示文摘 | Janice SC Chew Mohammed Saleem Christopher M | 2008 | Clin Biochem Rev2008，1，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员